Fiche société
University of California, Los Angeles
Traitements, essais et publications liés.
Traitements11programmes
Essais6liés
Publications3liées
SourceDBlocale
Traitements
11| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Deep Brain Stimulation (DBS)The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated. | Parkinson | Non applicable | À vérifier | United States | À vérifier |
| Optimization of VNS in Epileptic Patients to Induce CardioprotectionThis study is a non-randomized, prospective study in patients with a diagnosis of epilepsy and previously implanted FDA approved Vagus Nerve Stimulation (VNS) devices. The goal of this clinical investigation is to evaluate the effects of adjusting vagus nerve stimulation parameters to engage cardioprotective effects. | Épilepsie | NA | À vérifier | United States | À vérifier |
| Sonablate HIFU deviceThe Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using HIFU through clinical data and health-related quality of life (HRQOL) questionnaires. | Cancer | À vérifier | À vérifier | United States | À vérifier |
| ThiamineThe purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects. | Maladie coronarienne | Phase 1 | À vérifier | United States | À vérifier |
| Truvaga PlusIrritable bowel syndrome (IBS) is a chronic disorder of gut-brain interaction that causes abdominal pain and altered bowel habits. Many people with IBS also experience symptoms outside the bowel, such as headaches, widespread pain, poor sleep, anxiety, and depression; these symptoms are especially common in females. This study focuses on stress reactivity (SR), a persistent pattern of stress-system activity that may be linked to autonomic nervous system function, immune activity, the gut microbiome, and brain processing. The investigators will enroll adults with at least moderate IBS symptoms and randomly assign them to 8 weeks of non-invasive vagal nerve stimulation (nVNS) or Usual Care. Participants assigned to nVNS will use a handheld device on the left side of the neck at home twice daily. The investigators will compare changes in IBS severity and other physical symptoms and examine whether baseline or treatment-related changes in blood, stool, heart-rate variability, sex hormones, and brain imaging measures are associated with response. The study will also explore whether treatment effects and predictors differ by sex. | Maladie coronarienne | Non applicable | Traitement symptomatique | United States | À vérifier |
| Optimization of VNS in Epileptic Patients to Induce CardioprotectionThis study is a non-randomized, prospective study in patients with a diagnosis of epilepsy and previously implanted FDA approved Vagus Nerve Stimulation (VNS) devices. The goal of this clinical investigation is to evaluate the effects of adjusting vagus nerve stimulation parameters to engage cardioprotective effects. | Épilepsie | NA | À vérifier | United States | À vérifier |
| Deep Brain Stimulation (DBS)The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated. | Parkinson | À vérifier | À vérifier | United States, Argentina, Austria, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Poland, South Korea, Spain, Turkey (Türkiye), United Kingdom | À vérifier |
| Deep Brain Stimulation (DBS)The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated. | Parkinson | Non applicable | À vérifier | United States | À vérifier |
| Sonablate HIFU deviceThe Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using HIFU through clinical data and health-related quality of life (HRQOL) questionnaires. | Cancer | À vérifier | À vérifier | United States | À vérifier |
| ThiamineThe purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects. | Maladie coronarienne | Phase 1 | À vérifier | United States | À vérifier |
| Truvaga PlusIrritable bowel syndrome (IBS) is a chronic disorder of gut-brain interaction that causes abdominal pain and altered bowel habits. Many people with IBS also experience symptoms outside the bowel, such as headaches, widespread pain, poor sleep, anxiety, and depression; these symptoms are especially common in females. This study focuses on stress reactivity (SR), a persistent pattern of stress-system activity that may be linked to autonomic nervous system function, immune activity, the gut microbiome, and brain processing. The investigators will enroll adults with at least moderate IBS symptoms and randomly assign them to 8 weeks of non-invasive vagal nerve stimulation (nVNS) or Usual Care. Participants assigned to nVNS will use a handheld device on the left side of the neck at home twice daily. The investigators will compare changes in IBS severity and other physical symptoms and examine whether baseline or treatment-related changes in blood, stool, heart-rate variability, sex hormones, and brain imaging measures are associated with response. The study will also explore whether treatment effects and predictors differ by sex. | Maladie coronarienne | Non applicable | Traitement symptomatique | United States | À vérifier |
Essais cliniques
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Truvaga Plus | Maladie coronarienne | Non applicable | NCT07926945 | U54: nVNS RCT — Effects of nVNS on Stress Reactivity in IBS | NOT_YET_RECRUITING |
| Thiamine | Maladie coronarienne | Phase 1 | NCT06326996 | B1&CABG — Thiamine Intervention and Coronary Artery Bypass Grafting | RECRUITING |
| Sonablate HIFU device | Cancer | À vérifier | NCT03620786 | HIFU for Focal Ablation of Prostate Tissue: An Observational Study | RECRUITING |
| Deep Brain Stimulation (DBS) | Parkinson | Non applicable | NCT01845883 | Perceptual Decision Making Under Conditions of Visual Uncertainty | WITHDRAWN |
| Deep Brain Stimulation (DBS) | Parkinson | À vérifier | NCT02071134 | Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | RECRUITING |
| Optimization of VNS in Epileptic Patients to Induce Cardioprotection | Épilepsie | NA | NCT04387435 | Optimization of VNS in Epileptic Patients to Induce Cardioprotection | COMPLETED |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Deep Brain Stimulation (DBS) | Motor evoked potentials as markers of internal capsule current spread during deep brain stimulation for Parkinson's disease. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology | ||
| Deep Brain Stimulation (DBS) | Established and emerging neuromodulation for drug-resistant epilepsy. | Clinical neurology and neurosurgery | ||
| Deep Brain Stimulation (DBS) | Implantation of Deep Brain Stimulator Through Polyetheretherketone (PEEK) Cranioplasty. | The Journal of craniofacial surgery |